HU9603476D0 - N-terminally extended proteins expressed in yeast - Google Patents
N-terminally extended proteins expressed in yeastInfo
- Publication number
- HU9603476D0 HU9603476D0 HU9603476A HU9603476A HU9603476D0 HU 9603476 D0 HU9603476 D0 HU 9603476D0 HU 9603476 A HU9603476 A HU 9603476A HU 9603476 A HU9603476 A HU 9603476A HU 9603476 D0 HU9603476 D0 HU 9603476D0
- Authority
- HU
- Hungary
- Prior art keywords
- yeast
- proteins expressed
- terminally extended
- extended proteins
- terminally
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/62—Insulins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/62—DNA sequences coding for fusion proteins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
- C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DK71294 | 1994-06-17 |
Publications (2)
Publication Number | Publication Date |
---|---|
HU9603476D0 true HU9603476D0 (en) | 1997-02-28 |
HUT75840A HUT75840A (en) | 1997-05-28 |
Family
ID=8096676
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU9603476A HUT75840A (en) | 1994-06-17 | 1995-06-16 | Expression of n-terminally extended proteins in yeast |
Country Status (16)
Country | Link |
---|---|
EP (1) | EP0765395A1 (hu) |
JP (1) | JP3730255B2 (hu) |
CN (1) | CN1131312C (hu) |
AU (1) | AU2733595A (hu) |
BR (1) | BR9508053A (hu) |
CA (1) | CA2192943A1 (hu) |
CZ (1) | CZ363796A3 (hu) |
FI (1) | FI965030A (hu) |
HU (1) | HUT75840A (hu) |
IL (1) | IL114160A (hu) |
MX (1) | MX9606536A (hu) |
NO (1) | NO965411L (hu) |
PL (1) | PL317761A1 (hu) |
SG (1) | SG47883A1 (hu) |
WO (1) | WO1995035384A1 (hu) |
ZA (1) | ZA954983B (hu) |
Families Citing this family (42)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6500645B1 (en) | 1994-06-17 | 2002-12-31 | Novo Nordisk A/S | N-terminally extended proteins expressed in yeast |
ZA9610456B (en) * | 1995-12-20 | 1997-06-20 | Novo Nordisk As | N-terminally extended proteins expressed in yeast |
ES2306462T3 (es) * | 1996-12-13 | 2008-11-01 | Novartis Vaccines And Diagnostics, Inc. | Analisis y separacion de proteinas del factor de crecimiento derivadas de plaquetas. |
WO1998028429A1 (en) * | 1996-12-20 | 1998-07-02 | Novo Nordisk A/S | N-terminally extended proteins expressed in yeast |
KR20010034305A (ko) | 1998-01-23 | 2001-04-25 | 한센 핀 베네드 | 효모에서 원하는 폴리펩티드를 만드는 방법 |
CN1415019A (zh) | 1999-12-29 | 2003-04-30 | 诺沃挪第克公司 | 用于生产在酵母中具有改进发酵产量的胰岛素前体和胰岛素前体类似物的方法 |
US7595172B2 (en) | 2001-07-24 | 2009-09-29 | Novo Nordisk A/S | Method for making acylated polypeptides |
WO2003010185A2 (en) * | 2001-07-24 | 2003-02-06 | Novo Nordisk A/S | Method for making acylated polypeptides |
US20030082671A1 (en) | 2001-07-24 | 2003-05-01 | Thomas Hoeg-Jensen | Method for making acylated polypeptides |
WO2004085472A1 (en) * | 2003-03-27 | 2004-10-07 | Novo Nordisk A/S | Method for making human insulin precursors and human insulin |
ATE517119T1 (de) | 2003-12-03 | 2011-08-15 | Novo Nordisk As | Einzelketteninsulin |
CN102660614A (zh) | 2005-08-16 | 2012-09-12 | 诺沃-诺迪斯克有限公司 | 制备成熟胰岛素多肽的方法 |
EP2049149B1 (en) | 2006-07-31 | 2015-04-15 | Novo Nordisk A/S | Pegylated extended insulins |
JP5864834B2 (ja) | 2006-09-22 | 2016-02-17 | ノボ・ノルデイスク・エー/エス | プロテアーゼ耐性のインスリンアナログ |
WO2008037735A1 (en) | 2006-09-27 | 2008-04-03 | Novo Nordisk A/S | Method for making maturated insulin polypeptides |
JP5404411B2 (ja) | 2006-11-22 | 2014-01-29 | ノボ・ノルデイスク・エー/エス | 活性化カルボキシペプチダーゼの製造方法 |
CN101743252A (zh) | 2007-07-16 | 2010-06-16 | 诺沃-诺迪斯克有限公司 | 蛋白酶稳定化的、peg化的胰岛素类似物 |
US8575096B2 (en) | 2007-08-13 | 2013-11-05 | Novo Nordisk A/S | Rapid acting insulin analogues |
KR20100053561A (ko) | 2007-08-15 | 2010-05-20 | 노보 노르디스크 에이/에스 | 아실 및 알킬렌 글리콜 부분을 갖는 인슐린 유사체 |
JP5721432B2 (ja) | 2007-08-15 | 2015-05-20 | ノボ・ノルデイスク・エー/エス | アミノ酸含有アルキレングリコール反復単位を含むアシル部を有するインスリン |
PT2254906T (pt) | 2008-03-18 | 2017-01-03 | Novo Nordisk As | Análogos de insulina acilados, estabilizados contra proteases |
US9242011B2 (en) | 2008-04-01 | 2016-01-26 | Novo Nordisk A/S | Insulin albumin conjugates |
EP2340033B1 (en) | 2009-06-26 | 2013-10-09 | Novo Nordisk A/S | PREPARATION COMPRISING INSULIN, NICOTINAMIDE AND Arginine |
US8815541B2 (en) | 2009-11-25 | 2014-08-26 | Novo Nordisk A/S | Method for making polypeptides |
WO2011161083A1 (en) | 2010-06-23 | 2011-12-29 | Novo Nordisk A/S | Human insulin containing additional disulfide bonds |
KR20130036290A (ko) | 2010-06-23 | 2013-04-11 | 노보 노르디스크 에이/에스 | 추가 이황화 결합을 함유하는 인슐린 유도체 |
EP2585484A1 (en) | 2010-06-23 | 2013-05-01 | Novo Nordisk A/S | Insulin analogues containing additional disulfide bonds |
WO2012080320A1 (en) | 2010-12-14 | 2012-06-21 | Novo Nordisk A/S | Fast-acting insulin in combination with long-acting insulin |
JP2014501239A (ja) | 2010-12-14 | 2014-01-20 | ノヴォ ノルディスク アー/エス | インスリン、ニコチンアミドおよびアミノ酸を含む製剤 |
WO2012171994A1 (en) | 2011-06-15 | 2012-12-20 | Novo Nordisk A/S | Multi substituted insulins |
WO2013186138A1 (en) | 2012-06-14 | 2013-12-19 | Novo Nordisk A/S | Preparation comprising insulin, nicotinamide and arginine |
JP6735561B2 (ja) | 2012-12-03 | 2020-08-05 | メルク・シャープ・アンド・ドーム・コーポレーションMerck Sharp & Dohme Corp. | O−グリコシル化カルボキシ末端部分(ctp)ペプチド系のインスリンおよびインスリン類似体 |
WO2014195452A1 (en) | 2013-06-07 | 2014-12-11 | Novo Nordisk A/S | Method for making mature insulin polypeptides |
ES2784603T3 (es) | 2015-06-02 | 2020-09-29 | Novo Nordisk As | Insulinas con extensiones recombinantes polares |
EP3341403B1 (en) | 2015-08-25 | 2022-01-05 | Novo Nordisk A/S | Novel insulin derivatives and the medical uses hereof |
CN108026156A (zh) | 2015-08-25 | 2018-05-11 | 诺和诺德股份有限公司 | 新型胰岛素衍生物及其医学用途 |
WO2017032797A1 (en) | 2015-08-25 | 2017-03-02 | Novo Nordisk A/S | Novel insulin derivatives and the medical uses hereof |
BR112018072034A2 (pt) * | 2016-05-24 | 2019-02-12 | Novo Nordisk A/S | compostos mic-1 e usos dos mesmos |
RU2020108281A (ru) | 2017-08-17 | 2021-08-26 | Ново Нордиск А/С | Новые ацилированные аналоги инсулина и варианты их применения |
EP3807306A4 (en) * | 2018-06-18 | 2022-04-06 | Unichem Laboratories Limited | LEADER SEQUENCE FOR HIGHER EXPRESSION OF RECOMBINANT PROTEINS |
TWI773009B (zh) | 2019-12-11 | 2022-08-01 | 丹麥商諾佛 儂迪克股份有限公司 | 新穎之胰島素類似物及其用途 |
WO2023144240A1 (en) | 2022-01-26 | 2023-08-03 | Novo Nordisk Research Centre Oxford Limited | Glucose sensitive insulin derivatives and uses thereof |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2593518B1 (fr) * | 1985-05-02 | 1989-09-08 | Transgene Sa | Vecteurs d'expression et de secretion de l'hirudine par les levures transformees |
US5010182A (en) * | 1987-07-28 | 1991-04-23 | Chiron Corporation | DNA constructs containing a Kluyveromyces alpha factor leader sequence for directing secretion of heterologous polypeptides |
CA1340772C (en) * | 1987-12-30 | 1999-09-28 | Patricia Tekamp-Olson | Expression and secretion of heterologous protiens in yeast employing truncated alpha-factor leader sequences |
DK105489D0 (da) * | 1989-03-03 | 1989-03-03 | Novo Nordisk As | Polypeptid |
DK300090D0 (da) * | 1990-12-19 | 1990-12-19 | Novo Nordisk As | Fremgangsmaade til fremstilling af leadersekvenser |
WO1992013951A1 (en) * | 1991-02-04 | 1992-08-20 | The Salk Institute Biotechnology/Industrial Associates, Inc. | Production of human serum albumin in methylotrophic yeast cells |
-
1995
- 1995-06-15 ZA ZA954983A patent/ZA954983B/xx unknown
- 1995-06-15 IL IL114160A patent/IL114160A/en not_active IP Right Cessation
- 1995-06-16 PL PL95317761A patent/PL317761A1/xx unknown
- 1995-06-16 CZ CZ963637A patent/CZ363796A3/cs unknown
- 1995-06-16 CN CN95194181A patent/CN1131312C/zh not_active Expired - Lifetime
- 1995-06-16 MX MX9606536A patent/MX9606536A/es unknown
- 1995-06-16 WO PCT/DK1995/000250 patent/WO1995035384A1/en not_active Application Discontinuation
- 1995-06-16 JP JP50150596A patent/JP3730255B2/ja not_active Expired - Lifetime
- 1995-06-16 HU HU9603476A patent/HUT75840A/hu unknown
- 1995-06-16 EP EP95922440A patent/EP0765395A1/en not_active Ceased
- 1995-06-16 AU AU27335/95A patent/AU2733595A/en not_active Abandoned
- 1995-06-16 CA CA002192943A patent/CA2192943A1/en not_active Abandoned
- 1995-06-16 BR BR9508053A patent/BR9508053A/pt not_active Application Discontinuation
- 1995-09-16 SG SG1996004970A patent/SG47883A1/en unknown
-
1996
- 1996-12-16 FI FI965030A patent/FI965030A/fi unknown
- 1996-12-16 NO NO965411A patent/NO965411L/no unknown
Also Published As
Publication number | Publication date |
---|---|
HUT75840A (en) | 1997-05-28 |
JP3730255B2 (ja) | 2005-12-21 |
SG47883A1 (en) | 1998-04-17 |
CA2192943A1 (en) | 1995-12-28 |
WO1995035384A1 (en) | 1995-12-28 |
FI965030A0 (fi) | 1996-12-16 |
PL317761A1 (en) | 1997-04-28 |
FI965030A (fi) | 1997-02-14 |
CN1152942A (zh) | 1997-06-25 |
JPH10501695A (ja) | 1998-02-17 |
MX9606536A (es) | 1997-03-29 |
AU2733595A (en) | 1996-01-15 |
CZ363796A3 (en) | 1997-05-14 |
NO965411L (no) | 1997-02-14 |
BR9508053A (pt) | 1997-08-12 |
EP0765395A1 (en) | 1997-04-02 |
IL114160A0 (en) | 1995-10-31 |
IL114160A (en) | 2006-12-31 |
CN1131312C (zh) | 2003-12-17 |
ZA954983B (en) | 1996-02-14 |
NO965411D0 (no) | 1996-12-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SG47883A1 (en) | N-terminally extended proteins expressed in yeast | |
AU4714797A (en) | Improvements in or relating to contrast agents | |
AU1668795A (en) | Improvements in or relating to contrast agents | |
GB9603069D0 (en) | Improvements in or relating to gene expression | |
AU2316797A (en) | Shc proteins | |
AU3902297A (en) | Two human nsp-like proteins | |
IL133582A0 (en) | Mammalian neuro-growth factor like protein | |
GB9510830D0 (en) | Proteins | |
AU1677199A (en) | Improvements in or relating to ultrasonography | |
AU1945395A (en) | Use of xylanase in baking | |
GB9405629D0 (en) | Recombinant DNA for use in yeast | |
GB9423372D0 (en) | Proteins and their uses | |
IL115317A0 (en) | Proteins | |
HUP9801330A3 (en) | Novel pka-binding proteins and uses thereof | |
GB9413316D0 (en) | Novel proteins | |
GB9425624D0 (en) | Improvements in two stroke engines | |
AU3411999A (en) | Novel rnase-like protein and its use | |
GB9402906D0 (en) | Improvements in swatches | |
AU1617495A (en) | Novel protein PHBP-70 | |
AU4266197A (en) | Granulocyte chemotactic protein 2 variant | |
GB9305786D0 (en) | Recombinant dna for use in yeast | |
AUPM779694A0 (en) | Dustmite allergen denaturant | |
GB9004441D0 (en) | Protein production in yeast | |
AU706700C (en) | N-terminally chemically modified protein compositions and methods | |
GB9411089D0 (en) | Proteins |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
DFC4 | Cancellation of temporary protection due to refusal |